Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

The Environment for Health Care Decision-making: Collecting, Using and Understanding Comparative Effectiveness Research

Session Chair(s)

Kimberly  Westrich, MA

Kimberly Westrich, MA

Director, Health Services Research

National Pharmaceutical Council, United States

This session will provide an overview of how stakeholders view the environment for health care decision-making, an in-depth look at how payers view and use comparative effectiveness research (CER) studies for these decisions, and an innovative way to collect the patient data needed for these CER studies.

Learning Objective : Describe stakeholder views on the impact of comparative effectiveness research (CER) for health care decision-making; Discuss how payers consider and use CER to make decisions; Define models for collection of real-world, observational data directly through patients.

Speaker(s)

Kimberly  Westrich, MA

Monitoring Changes in the Environment for Health Care Decision-making

Kimberly Westrich, MA

National Pharmaceutical Council, United States

Director, Health Services Research

Joel S. Weissman, PhD

Translating CER into Medical Payment Policy: Views from Public and Private Payers

Joel S. Weissman, PhD

Harvard Medical School, United States

Associate Professor, Health Policy

John  Reites

Working Directly with Patients to Collect HEO/CER Data Using Innovative Hybrid Observational Research Models

John Reites

THREAD, United States

Chief Executive Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.